The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
Open accessAbstract
Fractalkine (FKN, CX3CL1) is a transmembrane chemokine expressed by neurons in the central nervous system (CNS). CX3CL1 signals through its unique receptor, CX3CR1, that is expressed in microglia. Within the CNS, fractalkine acts as a regulator of microglia activation in response to brain injury or inflammation. During the last decade, there has been a growing interest in the roles that the CX3CL1/CX3CR1 signaling pathway plays in the neuropathology of a diverse array of brain disorders. However, the reported results have proven controversial, indicating that a disruption of the CX3CL1 axis induces a disease-specific microglial response that may have either beneficial or detrimental effects. Therefore, it has become clear that the understanding of neuron-to-glia signals mediated by CX3CL1/CX3CR1 at different stages of diseases could provide new insight into potential therapeutic targets. Hence, the aim of this review is to provide a summary of the literature on the emerging role of CX3CL1 in animal models of some brain disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Briones, T. L., Woods, J., & Wadowska, M. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-13 · Cited by 35
RetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Fisher, R. S., Boas, W. V. E., Blume, W., Elger, C., Genton, P., Lee, P., & Engel, J. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.66104.x · Cited by 3,671
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Beghi, E., Berg, A., Carpio, A., Forsgren, L., Hesdorffer, D. C., Hauser, W. A., Malmgren, K., Shinnar, S., Temkin, N., Thurman, D., et al. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00273_1.x · Cited by 2,296
A new class of membrane-bound chemokine with a CX3C motif
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Parent, J. M., Yu, T. W., Leibowitz, R. T., Geschwind, D. H., Sloviter, R. S., & Lowenstein, D. H. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-10-03727.1997 · Cited by 1,871
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
Rowland, L. P., & Shneider, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442207 · Cited by 1,812
Wake, H., Moorhouse, A. J., Jinno, S., Kohsaka, S., & Nabekura, J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4363-08.2009 · Cited by 1,619
Microglial interactions with synapses are modulated by visual experience
Tremblay, M.-È., Lowery, R. L., & Majewska, A. K. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000527 · Cited by 1,542
Control of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531
An english translation of alzheimer’s 1907 paper, “über eine eigenartige erkankung der hirnrinde”
Stelzmann, R. A., Norman Schnitzlein, H., & Reed Murtagh, F. (1995) · Clinical Anatomy · doi:10.1002/ca.980080612 · Cited by 1,455
Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
Harrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176
Glia and epilepsy: excitability and inflammation
Devinsky, O., Vezzani, A., Najjar, S., De Lanerolle, N. C., & Rogawski, M. A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.11.008 · Cited by 867
Neuronal ‘On’ and ‘Off’ signals control microglia
Biber, K., Neumann, H., Inoue, K., & Boddeke, H. W. G. M. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.08.007 · Cited by 787
Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures
Bengzon, J., Kokaia, Z., Elmér, E., Nanobashvili, A., Kokaia, M., & Lindvall, O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10432 · Cited by 782
Ripps, M. E., Huntley, G. W., Hof, P. R., Morrison, J. H., & Gordon, J. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.689 · Cited by 722
Hundhausen, C., Misztela, D., Berkhout, T. A., Broadway, N., Saftig, P., Reiss, K., Hartmann, D., Fahrenholz, F., Postina, R., Matthews, V., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3775 · Cited by 713
Ravizza, T., Gagliardi, B., Noé, F., Boer, K., Aronica, E., & Vezzani, A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.08.012 · Cited by 699
Regulation of Tau Pathology by the Microglial Fractalkine Receptor
Bhaskar, K., Konerth, M., Kokiko-Cochran, O. N., Cardona, A., Ransohoff, R. M., & Lamb, B. T. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.023 · Cited by 639 · cited 1×
“Conversely, a follow-up study surprisingly revealed that ablation of the fractalkine receptor resulted in enhanced Tau pathology, as demonstrated by increased Tau phosphorylation and aggregation, which correlates with worsened behavioral and cognitive deficits [91,99].”
BackgroundEpilepsy and brain inflammation
Vezzani, A., Aronica, E., Mazarati, A., & Pittman, Q. J. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.033 · Cited by 603
Maphis, N., Xu, G., Kokiko-Cochran, O. N., Jiang, S., Cardona, A., Ransohoff, R. M., Lamb, B. T., & Bhaskar, K. (2015) · Brain · doi:10.1093/brain/awv081 · Cited by 595
The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis
Hirsch, L., Jette, N., Frolkis, A., Steeves, T., & Pringsheim, T. (2016) · Neuroepidemiology · doi:10.1159/000445751 · Cited by 571
Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease
Fuhrmann, M., Bittner, T., Jung, C. K. E., Burgold, S., Page, R. M., Mitteregger, G., Haass, C., LaFerla, F. M., Kretzschmar, H., & Herms, J. (2010) · Nature Neuroscience · doi:10.1038/nn.2511 · Cited by 562
Rate of cell death in parkinsonism indicates active neuropathological process
McGeer, P. L., Itagaki, S., Akiyama, H., & McGeer, E. G. (1988) · Annals of Neurology · doi:10.1002/ana.410240415 · Cited by 556
Microglial subtypes: diversity within the microglial community
Stratoulias, V., Venero, J. L., Tremblay, M., & Joseph, B. (2019) · The EMBO Journal · doi:10.15252/embj.2019101997 · Cited by 547
Lee, S., Varvel, N. H., Konerth, M. E., Xu, G., Cardona, A. E., Ransohoff, R. M., & Lamb, B. T. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100265 · Cited by 522 · cited 2×
“The fact that microglia proliferate faster and cluster around fibrillar amyloid plaques is probably due to dysregulated fractalkine/CX3CR1 signaling by deletion of the CX3CR1 receptor [25,92,93].”
BackgroundDe Simoni, M. G., Perego, C., Ravizza, T., Moneta, D., Conti, M., Marchesi, F., De Luigi, A., Garattini, S., & Vezzani, A. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00140.x · Cited by 510
Michelucci, A., Heurtaux, T., Grandbarbe, L., Morga, E., & Heuschling, P. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.02.003 · Cited by 411
Yamagata, M., Sanes, J. R., & Weiner, J. A. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00107-8 · Cited by 374
Fractalkine and CX3CR1 regulate hippocampal neurogenesis in adult and aged rats
Bachstetter, A. D., Morganti, J. M., Jernberg, J., Schlunk, A., Mitchell, S. H., Brewster, K. W., Hudson, C. E., Cole, M. J., Harrison, J. K., Bickford, P. C., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.11.022 · Cited by 364
Chapman, G. A., Moores, K., Harrison, D., Campbell, C. A., Stewart, B. R., & Strijbos, P. J. L. M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-j0004.2000 · Cited by 349
Proliferating resident microglia after focal cerebral ischaemia in mice
Denes, A., Vidyasagar, R., Feng, J., Narvainen, J., McColl, B. W., Kauppinen, R. A., & Allan, S. M. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600495 · Cited by 342
Production and neuroprotective functions of fractalkine in the central nervous system
Mizuno, T., Kawanokuchi, J., Numata, K., & Suzumura, A. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02867-1 · Cited by 339
Neuron–glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage
Sheridan, G. K., & Murphy, K. J. (2013) · Open Biology · doi:10.1098/rsob.130181 · Cited by 337
Faure, S., Meyer, L., Costagliola, D., Vaneensberghe, C., Genin, E., Autran, B., ALT, F., Groups, I. S., Delfraissy, J.-F., Group, S. S., et al. (2000) · Science · doi:10.1126/science.287.5461.2274 · Cited by 323
Microglia, seen from the CX3CR1 angle
Wolf, Y., Yona, S., Kim, K.-W., & Jung, S. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00026 · Cited by 316
Minocycline markedly protects the neonatal brain against hypoxic‐ischemic injury
Arvin, K. L., Han, B. H., Du, Y., Lin, S., Paul, S. M., & Holtzman, D. M. (2002) · Annals of Neurology · doi:10.1002/ana.10242 · Cited by 309
Huang, D., Shi, F., Jung, S., Pien, G. C., Wang, J., Salazar‐Mather, T. P., He, T. T., Weaver, J. T., Ljunggren, H., Biron, C. A., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5465com · Cited by 284
Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies
Irwin, D. J., Cohen, T. J., Grossman, M., Arnold, S. E., Xie, S. X., Lee, V. M.-Y., & Trojanowski, J. Q. (2012) · Brain · doi:10.1093/brain/aws013 · Cited by 281 · cited 1×
“Intracellular neurofibrillary tangles, as the second hallmark of AD pathology, are involved in the dispersion of microtubules and contribute to the progression of the disease [90].”
BackgroundMcDermott, D. H., Fong, A. M., Yang, Q., Sechler, J. M., Cupples, L. A., Merrell, M. N., Wilson, P. W. F., D’Agostino, R. B., O’Donnell, C. J., Patel, D. D., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16790 · Cited by 281
Angiogenesis: A Harmonized Target for Recovery After Stroke
Ergul, A., Alhusban, A., & Fagan, S. C. (2012) · Stroke · doi:10.1161/strokeaha.111.642710 · Cited by 277
Liu, Z., Condello, C., Schain, A., Harb, R., & Grutzendler, J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4403-10.2010 · Cited by 275 · cited 4×
“Notably, despite the increased density of microglia, there was no effect of CX3CR1 deletion on the degree of neuronal and synaptic damage surrounding the plaques [93].”
BackgroundInfluentialCho, S.-H., Sun, B., Zhou, Y., Kauppinen, T. M., Halabisky, B., Wes, P., Ransohoff, R. M., & Gan, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.254268 · Cited by 268
Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review
Minati, L., Edginton, T., Grazia Bruzzone, M., & Giaccone, G. (2009) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317508328602 · Cited by 268
Mesial Temporal Lobe Epilepsy: Pathogenesis, Induced Rodent Models and Lesions
Sharma, A. K., Reams, R. Y., Jordan, W. H., Miller, M. A., Thacker, H. L., & Snyder, P. W. (2007) · Toxicologic Pathology · doi:10.1080/01926230701748305 · Cited by 263
Genetics of Amyotrophic Lateral Sclerosis
Ghasemi, M., & Brown, R. H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024125 · Cited by 262
Role of α-Synuclein in Inducing Innate and Adaptive Immunity in Parkinson Disease
Allen Reish, H. E., & Standaert, D. G. (2015) · Journal of Parkinson’s Disease · doi:10.3233/jpd-140491 · Cited by 244
CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson’s disease
Pabon, M. M., Bachstetter, A. D., Hudson, C. E., Gemma, C., & Bickford, P. C. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-9 · Cited by 241
Absence of CX3CR1 impairs the internalization of Tau by microglia
Bolós, M., Llorens-Martín, M., Perea, J. R., Jurado-Arjona, J., Rábano, A., Hernández, F., & Avila, J. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0200-1 · Cited by 231
Neuroprotective Effect of Ketamine Administered After Status Epilepticus Onset
Fujikawa, D. G. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb00979.x · Cited by 226
Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge
Wynne, A. M., Henry, C. J., Huang, Y., Cleland, A., & Godbout, J. P. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.05.011 · Cited by 224
Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice
DiCarlo, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00292-5 · Cited by 223
Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury
Soriano, S. G., Amaravadi, L. S., Wang, Y. F., Zhou, H., Yu, G. X., Tonra, J. R., Fairchild-Huntress, V., Fang, Q., Dunmore, J. H., Huszar, D., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00033-4 · Cited by 222
Dommergues, M.-A., Plaisant, F., Verney, C., & Gressens, P. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00558-x · Cited by 222
Microglia centered pathogenesis in ALS: insights in cell interconnectivity
Brites, D., & Vaz, A. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00117 · Cited by 203
Lyons, A., Lynch, A. M., Downer, E. J., Hanley, R., O’Sullivan, J. B., Smith, A., & Lynch, M. A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06253.x · Cited by 202
The process of epileptogenesis: a pathophysiological approach
Dalby, N. O., & Mody, I. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200104000-00009 · Cited by 199
Tang, Z., Gan, Y., Liu, Q., Yin, J.-X., Liu, Q., Shi, J., & Shi, F.-D. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-26 · Cited by 193
Neuroinflammatory targets and treatments for epilepsy validated in experimental models
Aronica, E., Bauer, S., Bozzi, Y., Caleo, M., Dingledine, R., Gorter, J. A., Henshall, D. C., Kaufer, D., Koh, S., Löscher, W., et al. (2017) · Epilepsia · doi:10.1111/epi.13783 · Cited by 191
NMDA receptor activation during status epilepticus is required for the development of epilepsy
Rice, A. C., & DeLorenzo, R. J. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01285-7 · Cited by 184
Nitric Oxide and Reactive Oxygen Species in Parkinson's Disease
Tieu, K., Ischiropoulos, H., & Przedborski, S. (2003) · IUBMB Life · doi:10.1080/1521654032000114320 · Cited by 180
CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice
Fumagalli, S., Perego, C., Ortolano, F., & De Simoni, M. (2013) · Glia · doi:10.1002/glia.22474 · Cited by 178
Tickets to the brain: Role of CCR2 and CX3CR1 in myeloid cell entry in the CNS
Prinz, M., & Priller, J. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.015 · Cited by 172
CX3CL1 Is Neuroprotective in Permanent Focal Cerebral Ischemia in Rodents
Cipriani, R., Villa, P., Chece, G., Lauro, C., Paladini, A., Micotti, E., Perego, C., De Simoni, M.-G., Fredholm, B. B., Eusebi, F., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3611-11.2011 · Cited by 166
Chemokines in CNS injury and repair
Järve, A., & Müller, H. W. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1427-3 · Cited by 160
Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis
Lastres-Becker, I., Innamorato, N. G., Jaworski, T., Rábano, A., Kügler, S., Van Leuven, F., & Cuadrado, A. (2014) · Brain · doi:10.1093/brain/awt323 · Cited by 160
Arginase 1+ microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammation
Cherry, J. D., Olschowka, J. A., & O’Banion, M. K. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0411-8 · Cited by 152
Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002
Turner, M. R., Parton, M. J., Shaw, C. E., Leigh, P. N., & Al-Chalabi, A. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.995 · Cited by 148
Morganti, J. M., Nash, K. R., Grimmig, B. A., Ranjit, S., Small, B. J., Bickford, P. C., & Gemma, C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0539-12.2012 · Cited by 143
Sharma, S., Taliyan, R., & Singh, S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.05.052 · Cited by 142
Microglial Contact Prevents Excess Depolarization and Rescues Neurons from Excitotoxicity
Kato, G., Inada, H., Wake, H., Akiyoshi, R., Miyamoto, A., Eto, K., Ishikawa, T., Moorhouse, A. J., Strassman, A. M., & Nabekura, J. (2016) · eNeuro · doi:10.1523/eneuro.0004-16.2016 · Cited by 139
Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway
Lee, S., Xu, G., Jay, T. R., Bhatta, S., Kim, K.-W., Jung, S., Landreth, G. E., Ransohoff, R. M., & Lamb, B. T. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0853-14.2014 · Cited by 123
Fractalkine in the nervous system: neuroprotective or neurotoxic molecule?
Lauro, C., Catalano, M., Trettel, F., & Limatola, C. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12805 · Cited by 121
Wang, Z., Tsai, L., Munasinghe, J., Leng, Y., Fessler, E. B., Chibane, F. L., Leeds, P. R., & Chuang, D. (2012) · Stroke · doi:10.1161/strokeaha.112.652545 · Cited by 118
Eyo, U. B., Peng, J., Murugan, M., Mo, M., Lalani, A., Xie, P., Xu, P., Margolis, D. J., & Wu, L. (2016) · eNeuro · doi:10.1523/eneuro.0209-16.2016 · Cited by 118
de Vries, H. E., Kooij, G., Frenkel, D., Georgopoulos, S., Monsonego, A., & Janigro, D. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03702.x · Cited by 117
Fractalkine Over Expression Suppresses α-Synuclein-mediated Neurodegeneration
Nash, K. R., Moran, P., Finneran, D. J., Hudson, C., Robinson, J., Morgan, D., & Bickford, P. C. (2014) · Molecular Therapy · doi:10.1038/mt.2014.175 · Cited by 111
Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy
Nash, K. R., Lee, D. C., Hunt, J. B., Morganti, J. M., Selenica, M.-L., Moran, P., Reid, P., Brownlow, M., Guang-Yu Yang, C., Savalia, M., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.011 · Cited by 108
Brand, S., Hofbauer, K., Dambacher, J., Schnitzler, F., Staudinger, T., Pfennig, S., Seiderer, J., Tillack, C., Konrad, A., Göke, B., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00361.x · Cited by 103
Zujovic, V., Schussler, N., Jourdain, D., Duverger, D., & Taupin, V. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00259-4 · Cited by 102
Chandrasekar, B., Melby, P. C., Sarau, H. M., Raveendran, M., Perla, R. P., Marelli‐Berg, F. M., Dulin, N. O., & Singh, I. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207006200 · Cited by 101
Yoshida, H., Imaizumi, T., Fujimoto, K., Matsuo, N., Kimura, K., Cui, X., Matsumiya, T., Tanji, K., Shibata, T., Tamo, W., et al. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01699-8 · Cited by 96
Daoudi, M., Lavergne, E., Garin, A., Tarantino, N., Debré, P., Pincet, F., Combadière, C., & Déterre, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313457200 · Cited by 94
Fractalkine/CX3CR1 is involved in the cross-talk between neuron and glia in neurological diseases
Luo, P., Chu, S., Zhang, Z., Xia, C., & Chen, N. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.11.017 · Cited by 94
Fractalkine/CX 3 CL 1 modulates GABAA currents in human temporal lobe epilepsy
Roseti, C., Fucile, S., Lauro, C., Martinello, K., Bertollini, C., Esposito, V., Mascia, A., Catalano, M., Aronica, E., Limatola, C., et al. (2013) · Epilepsia · doi:10.1111/epi.12354 · Cited by 92
Ali, I. Y., Chugh, D., & Ekdahl, C. T. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.11.009 · Cited by 89
Castro‐Sánchez, S., García‐Yagüe, Á. J., López‐Royo, T., Casarejos, M. J., Lanciego, J. L., & Lastres‐Becker, I. (2018) · Glia · doi:10.1002/glia.23338 · Cited by 89
Therapeutic Angiogenesis for Brain Ischemia: A Brief Review
Fan, Y., & Yang, G. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9073-3 · Cited by 86
Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept
Epelbaum, S., Genthon, R., Cavedo, E., Habert, M. O., Lamari, F., Gagliardi, G. P., Lista, S., Teichmann, M., Bakardjian, H., Hampel, H. J., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.12.003 · Cited by 85
Mack, J. M., Schamne, M. G., Sampaio, T. B., Pértile, R. A. N., Fernandes, P. A. C. M., Markus, R. P., & Prediger, R. D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3472032 · Cited by 81
Chemokines as new inflammatory players in the pathogenesis of epilepsy
Cerri, C., Caleo, M., & Bozzi, Y. (2017) · Epilepsy Research · doi:10.1016/j.eplepsyres.2017.07.016 · Cited by 80
Altered Expression of CX3CL1 in Patients with Epilepsy and in a Rat Model
Xu, Y., Zeng, K., Han, Y., Wang, L., Chen, D., Xi, Z., Wang, H., Wang, X., & Chen, G. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.01.024 · Cited by 79
CX3CR1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis
López-López, A., Gámez, J., Syriani, E., Morales, M., Salvadó, M., Rodríguez, M. J., Mahy, N., & Vidal-Taboada, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096528 · Cited by 74
Thome, A. D., Standaert, D. G., & Harms, A. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140566 · Cited by 68
Suppressed pro-inflammatory response of microglia in CX3CR1 knockout mice
Mattison, H. A., Nie, H., Gao, H.-M., Zhou, H., Hong, J.-S., & Zhang, J. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.02.008 · Cited by 65
Rosito, M., Lauro, C., Chece, G., Porzia, A., Monaco, L., Mainiero, F., Catalano, M., Limatola, C., & Trettel, F. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00193 · Cited by 64
Winter, A. N., Subbarayan, M. S., Grimmig, B. A., Weesner, J. A., Moss, L. D., Peters, M. M., Weeber, E. J., Nash, K. R., & Bickford, P. C. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01828-y · Cited by 64
Mutational Analysis of the Fractalkine Chemokine Domain
Harrison, J. K., Fong, A. M., Swain, P. W., Chen, S., Yu, Y.-R., Salafranca, M. N., Greenleaf, W. B., Imai, T., & Patel, D. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010261200 · Cited by 63
Merino, J. J., Muñetón‐Gómez, V. C., Álvarez, M., & Toledano‐Díaz, A. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666151116125714 · Cited by 62
Ramsey, C. P., & Tansey, M. G. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.05.014 · Cited by 61
Dose-Dependent Differential Regulation of Cytokine Secretion from Macrophages by Fractalkine
Mizutani, N., Sakurai, T., Shibata, T., Uchida, K., Fujita, J., Kawashima, R., Kawamura, Y. I., Toyama‐Sorimachi, N., Imai, T., & Dohi, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7478 · Cited by 59
Yeo, S.-I., Kim, J.-E., Ryu, H. J., Seo, C. H., Lee, B. C., Choi, I.-G., Kim, D.-S., & Kang, T.-C. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.03.005 · Cited by 55
Lauro, C., Catalano, M., Trettel, F., Mainiero, F., Ciotti, M. T., Eusebi, F., & Limatola, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7599 · Cited by 54
Zujovic, V., & Taupin, V. (2003) · Methods · doi:10.1016/s1046-2023(02)00358-4 · Cited by 51
Zhang, L., Xu, J., Gao, J., Wu, Y., Yin, M., & Zhao, W. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0084 · Cited by 51
Scharfman, H. E., & Pedley, T. A. (2007) · Elsevier eBooks · doi:10.1016/b978-012088592-3/50035-9 · Cited by 48
Evidence for a protective role of the CX3CL1/CX3CR1 axis in a model of amyotrophic lateral sclerosis
Liu, C., Hong, K., Chen, H., Niu, Y., Duan, W., Liu, Y., Ji, Y., Deng, B., Li, Y., Li, Z., et al. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0204 · Cited by 48
Gan, A., Butoi, E. D., Manea, A., Simion, V., Stan, D. L., Parvulescu, M.-M., Călin, M., Mânduțeanu, I., & Simionescu, M. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1510-9 · Cited by 45
Re-Cloning the N27 Dopamine Cell Line to Improve a Cell Culture Model of Parkinson's Disease
Gao, L., Zhou, W., Symmes, B. A., & Freed, C. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160847 · Cited by 42
López-López, A., Gelpí, E., Lopategui, D. M., & Vidal-Taboada, J. M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0489-3 · Cited by 35
Lauro, C., Catalano, M., Paolo, E. D., Chece, G., de Costanzo, I., Trettel, F., & Limatola, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00472 · Cited by 34
Wenjing, Q., Li, Q., Luo, S., Wu, R., Pei, Z., & Huang, R. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.03.052 · Cited by 31
Fractalkine Gene Receptor Polymorphism in Patients With Multiple Sclerosis
Arlı, B., Ceyla, I., Menevşe, S., Yılmaz, A., & Alp, E. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.723079 · Cited by 29
Calvo, A., Moglia, C., Canosa, A., Cammarosano, S., Ilardi, A., Bertuzzo, D., Traynor, B. J., Brunetti, M., Barberis, M., Mora, G., et al. (2017) · Muscle & Nerve · doi:10.1002/mus.25653 · Cited by 27
Lü, Y., Xue, T., Yuan, J., Li, Y., Wu, Y., Xi, Z., Xiao, Z., Chen, Y., & Wang, X. (2008) · Clinical Science · doi:10.1042/cs20080347 · Cited by 26
Tetranectin is a potential biomarker in cerebrospinal fluid and serum of patients with epilepsy
Wang, L., Pan, Y., Chen, D., Xiao, Z., Xi, Z., Xiao, F., & Wang, X. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.01.022 · Cited by 26
Tristão, F. S. M., Lazzarini, M., Martin, S., Amar, M., Stühmer, W., Kirchhoff, F., Gomes, L. C., Lanfumey, L., Prediger, R. D., Sepulveda-Diaz, J. E., et al. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9557-5 · Cited by 22
Role of the Transcription Factor Nrf2 in Parkinson’s Disease: New Insights
Lastres‐Becker, I. (2017) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000340 · Cited by 20
Zhang, R., Wang, L., Wang, Y.-F., Wu, C., Lei, C.-L., Wang, M., & Ma, L. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16830 · Cited by 18
CX3CR1 polymorphisms and the risk of age-related macular degeneration.
Ma, B., Dang, G., Yang, S., Duan, L., & Zhang, Y. (2015) · PubMed · Cited by 11
Zujovic (2000) · doi:10.1002/(sici)1098-1136(20000215)29:4
Cited by
Microglia Phenotypes in Aging and Neurodegenerative Diseases
Wendimu, M. Y., & Hooks, S. B. (2022) · Cells · doi:10.3390/cells11132091 · Cited by 336
Microglia and Alzheimer’s Disease
Merighi, S., Nigro, M., Travagli, A., & Gessi, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112990 · Cited by 236
Inflammation context in Alzheimer’s disease, a relationship intricate to define
Novoa, C., Salazar, P., Cisternas, P., Gherardelli, C., Vera-Salazar, R., Zolezzi, J. M., & Inestrosa, N. C. (2022) · Biological Research · doi:10.1186/s40659-022-00404-3 · Cited by 206
Neuroinflammation in Huntington’s Disease: A Starring Role for Astrocyte and Microglia
Saba, J., Couselo, F. L., Bruno, J., Carniglia, L., Durand, D., Lasaga, M., & Caruso, C. (2022) · Current Neuropharmacology · doi:10.2174/1570159x19666211201094608 · Cited by 117
Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics
Lepiarz-Raba, I., Gbadamosi, I., Florea, R., Paolicelli, R. C., & Jawaid, A. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00382-w · Cited by 90
Metadata
- Authors
- Pawelec, P., Ziemka-Nalecz, M., Sypecka, J., & Zalewska, T.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-10-13
- Volume
- 9
- Issue
- 10
- Pages
- 2277
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3091912339
- Cited by
- 269
- References
- 127
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.